Verastem Inc. (VSTM) announced Saturday that data from studies of duvelisib were presented at the 23rd Congress of the European Hematology Association that was held in Stockholm, Sweden.
from RTT - Before the Bell https://ift.tt/2t9ey5W
via IFTTT
No comments:
Post a Comment